We determined serum ferritin, C-reactive protein (CRP), fibrinogen, and the erythrocyte sedimentation rate (ESR) in 73 patients with anemia of chronic disease. Nomograms of CRP, ESR, or fibrinogen vs ferritin concentrationswere constructed and used to estimate the iron store in bone marrow. Iron stores estimated from the nomograms were compared with the results of staining cytological bone marrow smears for iron, the reference method for evaluating iron in bone marrow. In contrast to the results of Wifte et al. (Gun Chem 1985;31 :1011; Am J Clin Pathol 1986;85:202-6 and 1988;90:85- values (5, 6) to diagnose or to exclude iron-deficiency anemia in patients with chronic disease,in an effort to minimize the number of bone-marrow examinations (4-6).
acute-phase reactants not influenced by changes in iron metabolism) vs ferritin are not suitable to correct for the acute-phase component of changes in ferritin concentrations. For ferritin concentrations <70 1zg/L,we found that iron deficiency, as judged from bone marrow iron stain, apparently was always present.
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Nearly 75% of the anemias in clinical practice are caused either by true irondeficiency or by poor utilization ofiron. The latter istypical foranemia ofchronic disease (1) . Anemia of chronic disease is defined as anemia associated with chronic infectious, inflammatory, traumatic, or neoplastic illnessand with characteristic disturbances of iron metabolism (1) (2) (3) . For these patients the concentrations of iron measured in serum are low, despite iron stores that range from adequate to increased.
Measurement of ferritin concentration in serum is often recommended as a useful estimate of iron stores or of iron deficiency. However, ferritin is also a so-called positive acute-phase protein. Therefore, especially in chronic disease, measurement of ferritin is not reliable for estimating bone marrow iron deficiency or overload. Apart from inflammation, liver cell damage can also increase the ferritin concentration,and in some malignancies very high ferritin concentrations have been measured, which are obviously not related to the body iron store. suggested that ferritin concentrations, if corrected for the acute-phase response, could still be used to estimate the iron stores in bone marrow, even in patients with anemia of chronic disease. (5, 6) to diagnose or to exclude iron-deficiency anemia in patients with chronic disease,in an effort to minimize the number of bone-marrow examinations (4) (5) (6) .
To test the procedures suggested by Witte et al., we also examined the relation between ferritin concentrations and the ESR or between serum ferritin concentrations and CRP or fibrinogen concentrations, i.e., acutephase markers not influenced by changes in iron metabolism. Staining of iron in cytologically obtained bone marrow was used as a reference method to determine the amount of iron in bone marrow.
Materials and Methods

Study population.
We studied 73 patients with anemia and chronic disease (30 men and 43 women) from the Departments of Internal Medicine and Rheumatology. Bone marrow aspirates and serum samples were taken during the same period. Informed consent was given by all patients. The criteria for patients to be included in the study were patients with liver disease, as determined from abovenormal transaminase concentrations in serum, were excluded from the study.
Methods.
Bone marrow aspirates were obtained from the sternum; all smears were stained with May Grunwald-Giemsa and Perls iron stain. The grade of staining was classified by microscopic evaluation of macrophage staining (absent, trace, or positive) and sideroblast staining (>20% is positive). method of Clauss (7) , and the ESR was determined according to Westergren (8) . CRP was measured immunoturbidimetrically (9) with a Cobas-Fara centrifugal analyzer, with antibodies and standard from Atlantic Antibodies (cat. no. 80285; obtained from Baxter, Maarssen, The Netherlands).
Results
As judged from bone marrow iron stain, 26 patients had "absent" iron stores, and eight patients had "trace" amounts. The remaining 39 patients were positive with respect to iron store in bone marrow. Analogous to the nomogram introduced by Witte et al. (6) , Figure 1 shows data only for patients with serum ferritin concentrations <160 p.gfL (n = 30); the data for this subpopulation are presented in Table 1 . By this nomogram, six patients would be incorrectly diagnosed as having sufficient bone marrow iron stores, and two patients with a trace of iron (as judged from cytological examination) would also be classified as having adequate iron stores. No significant correlation was observed between CRP and ferritin concentrations <160 j.z.gfL. The results observed for fibrinogen vs ferritin are comparable with those for the ESR vs ferritin (see Table 1 ). All patients with ferritin concentrations <70 j.tg/L were iron-deficient, as determined by iron stain of their bone marrow.
The mean, standard deviation, and median for the different analytes and for the different subpopulations are presented in Table 2 . between ferritin concentrations and the ESR, the nomogram cannot be used to predict the iron store in bone marrow, because differentiation between groups of patients with absent,trace, or positive iron store, asjudged from bone marrow iron stain,appears insufficient.
For CRP vs ferritin forthe overall group (n = 72), the correlation is also highly significant. However, discrimination between patients with absent, trace, or positive iron stores is still not possible. Data are presented in Table 1 . rheumatoid arthritis, the same patient population considered by Witte et al. (6) . For this subgroup, differentiation between patients with absent, trace, or positive iron store in bone marrow also appears insufficient.
Discussion
As stated before, serum ferritin concentration can be used as a reliable marker to predict iron stores in bone marrow only when an acute-phase reaction is absent (10) (11) (12) . In the present study, apart from a significant correlation, we observed no useful relation between ESR, fibrinogen, and ferritin concentrations. The relation between CRP and ferritin concentrations <160 pgfL did not reach statistical significance, in contrast to the results of Witte et al. (4) (5) (6) .
If we used the nomogram suggested by Witte et al. (ferritin concentrations <160 gfL vs ESR, n = 30), six iron-deficient patients and two patients with trace iron stores (as judged from bone marrow iron stain) would be incorrectly diagnosed as having sufficient iron stores. Construction of nomograms that would include patients with ferritin concentrations >160 gfL did not improve the value of the nomograms suggested by Witte et al.
(4-6).
Although highly significant correlations have been observed for both ESR and CRP vs ferritin (P <0.001), the nomograms do not differentiate between patients with absent, trace, or positive iron stores in bone marrow. The overlap between the groups with absent, trace, or positive bone marrow iron stores is even greater when the nomograms with ferritin concentrations <160 p.gfL are used (compare Figure 1 with Figure 2 ). In our study, patients with ferritin concentrations <70 jgfL appeared to be all iron-deficient, as judged from bone marrow iron stain, which is in accordance with other studies (13-15) , although a cutoff value of 100 j.tg/L has also been reported (16) . This difference might be caused by differences in the standardization of the ferritin test kits used (17) .
Discrepancies between our results and those of Witte et al. (4) (5) (6) cannot be ascribed to the use of different test kits for the determination of ferritin. The correlations between several ferritin test kits were good (17) . Moreover, if the discrepancies were caused by differences in standardization, construction of nomograms for ferritin concentrations extending over different ferritin concentration ranges (Table 2) should give results comparable with those of Witte et al. (6) , but this is not the case.
To exclude discrepancies that might be introduced by differences in patient population, we presented results (Figure 3) , the subpopulation comparable with the patient population of Witte et al. (6) . Again, no differentiation appeared possible between patients with absent, trace, or positive iron stores in bone marrow.
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We conclude that the nomograms suggested by Witte et al. (4) (5) (6) cannot be used to estimate iron deficiency in patients with anemia of chronic disease. The idea of correcting the serum ferritin for increasesattributable to the acute-phase response, by using an acute-phase protein that is not influenced by changes in iron metabolism, is attractive. However, as our investigations have shown, one cannot eliminate the acute-phase component of serum ferritin changes by using the ESR, CRP, or fibrinogen as independent acute-phase markers. Hence, we conclude that the use of a "corrected value" for serum ferritin to evaluate iron deficiency in patients with anemia of chronic disease appears not possible.
